The QualityStocks Daily Friday, August 10th, 2018

Today's Top 3 StockMarketWatch

MissionIR (TMSR) +55.69%

StockMarketWatch (CTXR) +48.25%

TopPennyStockMovers (GRYN) +39.86%

The QualityStocks Daily Stock List

Scientific Industries, Inc. (SCND)

Amigo Bulls, MicroSmallCap, InvestorsHub, Proactive Investors, Marketbeat, 4-Traders, Zacks, WalletInvestor, Simply Wall St, and The Street reported on Scientific Industries, Inc. (SCND), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Scientific Industries, Inc. designs, manufactures, and markets an array of laboratory equipment. These include the world-renowned Vortex-GenieÒ 2 Mixer and TorbalÒ balances. The Company also produces and sells customized catalyst research instruments. Furthermore, it engages in the research, development and production of bioprocessing systems and methods. Scientific Industries is based in Bohemia, New York.

Typically, the Company’s products are used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, chemical companies, and medical device manufacturers.

Scientific Industries offers vortex mixers to mix the contents of test tubes, beakers, and other containers by placing such containers on a rotating cup or other attachments. It also offers divers mixers and shakers, such as high-speed touch mixers, cell disruptors, microplate mixers, vortex mixers incorporating digital control and display, and more.

Furthermore, the Company provides benchtop multi-purpose rotators and rockers to rotate and rock different containers; refrigerated incubators and incubator shakers; magnetic stirrers, and large volume magnetic and four-place general purpose stirrers in analog and digital versions, among others.

Scientific Industries also provides bioprocessing systems consisting of coaster systems using disposable sensors for vessels with volumes ranging from 250 milliliter to 5 liters; and mechanical balances, moisture analyzers, and force gauges. Moreover, it offers pharmacy, laboratory, and industrial digital scales.

In May, Scientific Industries reported a Net Loss of $37,700 ($.03 per common share) and a Net Loss of $351,500 ($.24 per common share) for the three and nine months ended March 31, 2018 versus Net Income of $65,600 ($.04 per common share) and $62,200 ($.04 per common share) for the three and nine months ended March 31, 2017.

The losses incurred for the three and nine-month periods ended March 31, 2018 were mainly due to accounting adjustments required to reflect an increase in current and anticipated future royalty payment obligations of Scientific Industries under license agreements with third party licensors of intellectual property (IP) relating to its Bioprocessing Operations.

The Company announced in May that it launched the Genie Temp-Shakers. This is a new line of inventive incubated shakers. The new products will complement and enhance the Company's Genie brand benchtop laboratory equipment line.

 

Scientific Industries, Inc. (SCND), closed Friday's trading session at $3.24, down 0.31%, on 400 volume with 4 trades. The average volume for the last 60 days is 876 and the stock's 52-week low/high is $2.86/$3.75.

chart

Covalon Technologies Ltd. (CVALF)

Penny Stock Tweets, Stockhouse, Barchart, Wallet Investor, 4-Traders, InvestorsHub, CapitalCube, OTC Markets, TradingView, InvestorsHangout, Proactive Investor, Penny Stock Picks, and Stockwatch reported on Covalon Technologies Ltd. (CVALF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Covalon Technologies Ltd. is an advanced medical technologies company listed on the OTC Markets Group’s OTCQX. Covalon researches, develops and commercializes new healthcare technologies. Its patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon Technologies has its corporate office in Mississauga, Ontario.

The Company’s technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. Its Advanced Wound Care line has been specially designed for the successful treatment of a broad array of wounds.

Regarding Infection Prevention, Covalon Technologies has its highly lubricious and top-quality antimicrobial protection SilverCoat™ Foley catheter. In addition, the Company has its dual antimicrobial silicone adhesive platform across the MediClear™ PreOp, SurgiClear™ and IV Clear™ brands.

Moreover, Covalon’s Perioperative Care brands, MediClear™ and SurgiClear™ offer a range of care throughout a patient’s surgical journey. Covalon has its Technology platforms. These are its Biomatrix Platform, its Antimicrobial Silicone Platform, and its Medical Coating Platform.

Covalon Technologies has established a Special Committee of the Board of Directors to evaluate potential acquisitions, strategic alliances, as well as partnerships. This is in response to the interest generated following the Company’s earlier announcement of its $100 million contract awards in the Middle East.

The Company reported Q2 Revenue of $5,727,275 and a Net Loss of $479,082 for the three months ended March 31st, 2018. It reported Revenue of $12,131,980 and Net Income of $44,263 for the six months ended March 31st, 2018.

Yesterday, Covalon Technologies announced that it entered into a new acquisition and operating banking credit facility with HSBC Bank Canada. This credit facility provides the Company with up to $17 million of credit.

In support of Covalon Technologies, Export Development Canada (EDC) has partnered with HSBC to provide partial guarantees under the banking facility. The credit facility will permit Covalon to fund its acquisition plans, which the Company stated are proceeding well.

Covalon Technologies Ltd. (CVALF), closed Friday's trading session at $5.91, up 3.92%, on 2,000 volume with 13 trades. The average volume for the last 60 days is 4,303 and the stock's 52-week low/high is $0.25/$7.12.

chart

Petrolia Energy Corp. (BBLS)

MarketWatch and Market Exclusive reported on Petrolia Energy Corp. (BBLS), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Petrolia Energy Corp.’s chief focus is utilizing cutting-edge technology and the implementation of its own pioneering, proprietary technologies to improve the recoverability of existing oil fields. The Company’s team of experts has a first-rate record of converting oil fields into compliant, producing, and profitable entities. Petrolia’s main objectives are to locate undervalued assets, identify properties with resolvable environmental and mechanical issues and lessening lift costs resulting in increased shareholder value.

Petrolia Energy has its headquarters in Houston, Texas. The Company formerly went by the name Rockdale Resources Corp. A domestic oil exploration and production enterprise, Petrolia Energy’s shares trade on the OTC Markets Group’s OTCQB.

The Company concentrates on new oil wells in established areas of oil production. Petrolia has more than 80 years of operational and management experience throughout the energy industry.

Petrolia Energy announced in October of 2016, that it purchased a 90 percent working interest (WI) by way of a purchase and sale agreement (PSA) and a share exchange agreement (SEA) with Jovian Petroleum Corp. and its subsidiaries, Jovian Resources, LLC and SUDS Properties, LLC, increasing its ownership to 100 percent WI for the Slick Unit Dutcher Sands (SUDS) field in Creek County, Oklahoma.

In 2017, Petrolia Energy completed the acquisition of a 60 percent net WI in the Twin Lakes San Andres Unit (TLSAU) lease, in Chaves County, New Mexico. This brings the Company’s total ownership of TLSAU to 100 percent.

On the whole, the TLSAU lease includes 4,864 gross and net acres; 2,292,903 barrels of 1P reserves; 44 existing vertical oil production wells, 12 that are presently producing; 44 existing injection wells for water flood and/or CO2 injection for enhanced oil recovery (EOR); wide-ranging surface infrastructure, and a dedicated Caprock well to supply future water flood operations.

Last week, further to Petrolia Energy’s press release dated December 5, 2017, the Company announced that it completed the acquisition of Bow Energy Ltd. Petrolia Energy acquired all of the issued and outstanding common shares in the capital of Bow. The Acquisition closed on February 27, 2018. Bow Energy is a Canadian based oil and natural gas company.

The acquired assets of Bow Energy comprise greater than 948,000 net acres onshore North Sumatra, Indonesia that consists of interests in five production-sharing contracts (PSCs) and one Joint Study Agreement (JSA) with the Indonesian government. These assets are surrounded by existing transportation infrastructure and significant discoveries by Repsol, ConocoPhillips and Chevron.

Petrolia Energy Corp. (BBLS), closed Friday's trading session at $0.07, up 7.53%, on 12,200 volume with 2 trades. The average volume for the last 60 days is 84,962 and the stock's 52-week low/high is $0.051/$0.47.

chart

Ethos Gold Corp. (ETHOF)

4-Traders, The Street, Stockhouse, MarketWatch, InvestorsHub, YCharts, Streetwise Reports, and TradingView reported on Ethos Gold Corp. (ETHOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Ethos Gold Corp. focuses on the acquisition and exploration of mineral properties internationally. At present, it holds one property in the White Gold District in the Yukon Territory. Ethos Gold has 100 percent ownership in the WC property. The Company mainly explores for gold, antimony, arsenic, lead, and silver deposits.

OTCQB-listed, Ethos Gold has its corporate office in Vancouver, British Columbia. Incorporated in 2007, the Company previously went by the name Ethos Capital Corp. It changed its name to Ethos Gold Corp. in April of 2012.

The Company’s WC property consists of 44 contiguous quartz claims totaling approximately 815 ha. The WC property is a target for intrusion-related 'Pogo-style' mineralization or fault controlled epithermal systems such as the nearby Coffee Deposit.

In 2012, Ethos Gold contracted Ground Truth Exploration, Inc. to conduct a small 301 soil geochemical sampling program for the WC property. This was completed in July of 2012.

The intention of the program was to identify areas of interest based on anomalous gold in soil values and to establish the mineral potential of the property. Samples were collected along 10 sample lines. Individual samples were collected with 50 meters between stations along traverse lines.

Fourteen sample sites returned values in excess of 10 ppb Au with a maximum value of 171 ppb Au. The sample with the second highest gold concentration (119 ppb Au) has coincident anomalous antimony (19 ppm Sb), arsenic (117 ppm As), lead (200 ppm Pb), and silver (13 ppm Ag).

The anomalous multi-element chemistry is similar to that identified by Ethos Gold at the Betty property, attributed to bonanza vein mineralization derived from and related to Western Copper's Casino Au-Cu-Mo porphyry.

Ethos has working capital of $6.5 million and 47.3 million shares issued and outstanding. The Company retains a highly qualified and successful management team. Mr. Craig Roberts, P.Eng, is the Company’s Interim President and Chief Executive Officer, Director and Vice President of Corporate Development. Mr. Roberts is a mining engineer. He has more than 30 years of operations, consulting, and investment banking experience.

Ethos Gold Corp. (ETHOF), closed Friday's trading session at $0.110369, even for the day. The average volume for the last 60 days is 2,613 and the stock's 52-week low/high is $0.10/$0.231.

chart

Hochschild Mining PLC (HCHDF)

Zacks, YCharts, Stockhouse, The Street, 4-Traders, Dividend Investor, Wallet Investors, and OTC Markets reported on Hochschild Mining PLC (HCHDF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Hochschild Mining PLC engages in the exploration, mining, processing, and sale of silver and gold deposits in the Americas. A precious metals enterprise, the Company is a leading underground precious metals producer focusing on high grade silver and gold deposits.

Hochschild Mining is headquartered in Lima, Peru. The Company also has a corporate office in London, United Kingdom (UK) and an office in Argentina.

Hochschild Mining currently operates four underground mines. Three are in southern Peru and one is in southern Argentina.  All of the Company’s underground operations are epithermal vein mines. The primary mining method used is cut and fill. The ore at Hochschild’s operations is processed into silver-gold concentrate or dore.

Regarding present operations, Inmaculada is the Company’s flagship asset. Inmaculada is a 20,000 hectare two-third gold and one-third silver mine consisting of 40 mining concessions located in the Ayacucho Department in southern Peru.

The Arcata unit is situated in the Department of Arequipa in southern Peru. It is approximately 300 kilometers from the city of Arequipa, on a 47,000-hectare site. Arcata is a 100 percent owned underground operation.

The Pallancata silver/gold property is positioned in the Department of Ayacucho in southern Peru, roughly 160 kilometers from the Arcata operation. Pallancata commenced production in 2007. Hochschild Mining owns 100 percent of the operation.

The San Jose silver-gold mine is in Argentina, in the Santa Cruz province, 1,750 kilometers south-southwest of Buenos Aires. The property covers a total area of 50,491 hectares. The property consists of 46 contiguous mining concessions totaling 40,499 hectares and an exploration permit covering almost 10,000 hectares.

Last month, Hochschild Mining announced that it delivered a new record half of attributable production with 268,237 gold equivalent ounces or 19.9 million silver equivalent ounces chiefly driven by considerable increases at Inmaculada and Pallancata, and another strong result from the 51 percent owned San Jose mine.

Hochschild reiterates that its all-in sustaining cost (AISC) for 2018 is on course to be $960-$990 per gold equivalent ounce ($13.0-13.4 per silver equivalent ounce).

Regarding Brownfield exploration at Inmaculada, in Q2 Hochschild Mining continued its wide-ranging drilling programme with encouraging results indicating significant additions to the deposit's resource base close to the existing mine infrastructure. The focus of the present campaign is to the east of the Angela vein with close to 20,000m of resource drilling carried out in Q2 centered on the Millet, Divina, Lola and Lizina veins.

Hochschild Mining PLC (HCHDF), closed Friday's trading session at $2.287, even for the day. The average volume for the last 60 days is 2,773 and the stock's 52-week low/high is $2.287/$4.37.

chart

Rennova Health, Inc. (RNVA)

Barchart, Preferred Stock Channel, Street Insider, StockTwits, InvestorsHub, and Stockhouse reported on Rennova Health, Inc. (RNVA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Rennova Health, Inc. is a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers. The Company opened its first rural hospital in Oneida, Tennessee on August 8, 2017. Rennova Health delivers an efficient, effective patient experience and first-rate clinical outcomes. The Company is based in West Palm Beach, Florida. Rennova Health has its Medytox Diagnostics subsidiary.

Essentially, Rennova Health is a single-source healthcare solutions company. It centers on serving essential healthcare categories, particularly those with unmet needs and major opportunities for innovation-driven solutions. The Company develops and operates progressive businesses, systems and services to support better treatment outcomes, more cost-effective patient care, and optimized revenue streams.

Rennova Health’s solutions include industry-leading diagnostic laboratory testing and analytics for precision medicine, and specialized and streamlined EHRs and other essential software services. Its solutions also include complete medical billing and financial services for enhanced revenue cycle management.

The Big South Fork Medical Center opened under Rennova Health’s ownership with services that include a 24/7 emergency department along with radiology services that include X-ray, CT scan and ultrasound. Furthermore, other available services include a laboratory, respiratory therapy, physical therapy, a medical/surgical unit, and swing beds.

Rennova’s Medytox Diagnostics subsidiary owns and operates five high-complexity CLIA-certified labs strategically located across the nation. These labs specialize in urine drug testing for prescription medications, drugs of abuse and complete pain medication testing.

The labs also provide testing services in the areas of clinical chemistry, toxicology, hematology, immunology, serology, bacteriology and esoteric testing services, including neurotransmitter testing, with a wide array of sampling options that include the Company’s proprietary methodology.

Rennova Health also has its comprehensive medical billing services company, Medical Billing Choices (MBC). MBC operates as the in-house billing company for all Rennova Health businesses and labs.

Recently, Rennova Health announced that its flagship Laboratory, EPIC Reference Labs, Inc. (EPIC), successfully met the Laboratory Accreditation Program Standards for Accreditation from the College of American Pathologists (CAP). Since 2015, EPIC has been operating as a urine toxicology testing laboratory in Riviera Beach, Florida. Under the CAP Accreditation, EPIC Reference Labs has been accredited for the All Common, Chemistry, Director/Organizational Assessment, Hematology, Immunology, Laboratory Central, Special Chemistry, Toxicology and Urinalysis testing services. In addition, subspecialty accreditation was granted for Endocrinology, General Immunology, Hematology, Routine Chemistry, Toxicology, Urinalysis and Syphilis Serology.

At the end of January, Rennova Health announced that it entered into a definitive asset purchase agreement to acquire an acute care hospital in Jamestown, Tennessee. The hospital, known as Tennova Healthcare - Jamestown, and its associated assets are being acquired from Community Health Systems, Inc. (CYH).

Tennova Healthcare - Jamestown is a fully operational 85-bed facility. The expectation is that this transaction will close in Q2 of 2018, subject to customary regulatory approvals and closing conditions.

Currently, Rennova Health operates in three synergistic divisions. One is clinical diagnostics via its clinical laboratories. The second is supportive software solutions to healthcare providers. This includes electronic health records (EHR), laboratory information systems (LIS) and medical billing services. The third is the recent addition of the hospital in Tennessee.

Rennova Health, Inc. (RNVA), closed Friday's trading session at $0.0009, up 28.57%, on 43,664,744 volume with 85 trades. The average volume for the last 60 days is 88,862,842 and the stock's 52-week low/high is $0.0006/$4.7805.

chart

Altamira Gold Corp. (EQTRF)

Capital Equity Review, Spotlight Growth, 4-Traders, StreetWise Reports, Junior Mining Network, Barchart, InvestorX, Stockwatch, MarketWatch, Stockhouse, WalletInvestor, and Stockscores reported on Altamira Gold Corp. (EQTRF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Altamira Gold Corp. engages in the acquisition, exploration, development, and mining of mineral properties in Canada and Brazil. A junior natural resource enterprise, the Company formerly went by the name Equitas Resources Corp. It changed its name to Altamira Gold Corp. in April 2017. Incorporated in 1994, Altamira Gold is based in Vancouver, British Columbia.

The Company is concentrating on the exploration and development of gold deposits within the Juruena belt of western Brazil. Altamira has a Brazil emphasis. It has 12 license areas comprising 200,000-plus ha in the prolific Juruena gold belt (7–10M oz of artisanal gold production).

Altamira Gold also has its advanced Cajueiro Project. This project has an NI 43-101 (National Instrument 43-101) resource of Indicated Resources of 214,000 oz Au and Inferred Resources of 204,000 oz Au plus an additional 79,000 oz at 1.61 g/t Au in oxides (as Saprolite). Two new zones were discovered at the Cajueiro Project in 2017. The two new zones discovered are at Baldo East and Toninho.

In addition, the Company has its Crepori Project. This Project is 8,323 ha with historical small-scale production. The Crepori Project is 105 km SSW of Eldorado Gold’s TZ Project. Surface sampling at Crepori has returned values up to 1022.98 g/t gold with around 10 percent of surface samples returning +5 g/t gold.

Additional trenching started on April 26, 2018 within the Baldo East target area at the Cajueiro project in western Brazil. The trench program will consist of a minimum of 1000 meters. The design of this program is to further extend the strike of a number of high-grade east-west trending mineralized structures in the Baldo East target area of the Cajueiro project.

In June, Altamira Gold provided results from a recent program of soil sampling at the Santa Helena project set within the eastern part of the Juruena belt in Mato Grosso, Brazil. The results follow recent surface rock sample results that identified high grade gold values from grab samples in numerous areas (averaging 31.2g/t Au + 0.13% Cu for 17 samples) from the Flecha Dourada target, 19.0g/t gold + 0.11% Cu from Gabriel for 20 samples, 24.6g/t gold from 6 rock samples from the Dorival target and 7.2g/t gold from 6 rock samples from the Tucura target, and substantial amounts of copper.

Recently, Altamira Gold announced that it completed the initial phase of the 2018 trenching campaign in the Baldo target area within the Cajueiro project in the north of the Alta Floresta Belt, in the states of Mato Grosso and Para, Brazil. Seven new trenches were excavated in the Baldo and Matrincha target areas comprising a total strike length of 1,218 meters.

Altamira Gold Corp. (EQTRF), closed Friday's trading session at $0.096, up 9.46%, on 45,800 volume with 10 trades. The average volume for the last 60 days is 15,212 and the stock's 52-week low/high is $0.0659/$0.288.

chart

AmpliTech Group, Inc. (AMPG)

Trading Wall St, fusionspicks, Jet-Life Penny Stocks, OTCMagic, Ascending Stocks, Penny Stock Gainers, RockingPennyStocks, BestStocksDaily, Wallstreetbuzz, AllPennyStocks, SmallCapVoice, PennyStocks24, Information Solutions Group, Pumps and Dumps, HoleinOneStocks.net, HotStockProfits, and Fortune Penny Stocks reported on AmpliTech Group, Inc. (AMPG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF Low Noise Amplifiers (LNA) and Power Amplifiers (PA). These are for the domestic and global, SATCOM, Space, and Military markets. Additionally, the Company provides consulting services to help with any microwave components or systems design problems. AmpliTech sells its products by way of sales representatives and distributors in North America, Europe, and Asia. OTCQB-listed, AmpliTech Group is based in Bohemia, New York.

The Company’s designs cover the frequency spectrum from 50 kHz to 40 GHz – eventually providing designs up to 100 GHz. AmpliTech can provide complex, custom solutions for almost any custom requirements presented to it. It can provide contract assembly of customers' own designs.

AmpliTech provides its customers with consulting services for their system development. In addition, the Company provides technical assistance in integration and packaging technologies and microwave sub-systems and amplifier related sub-assemblies.

AmpliTech utilizes the most contemporary CAD microwave simulation technology to design and develop from concept to final manufacture of a deliverable product with first-rate accuracy. AmpliTech expects to release new products targeted at the wireless and satellite markets, which will provide advanced technology and performance.

AmpliTech Group announced in 2017 that it entered into a Joint Venture (JV) Agreement with Trusted Networks, Inc. (TN). TN is a New York, New York based private company with facilities in Colorado Springs and Nashua, New Hampshire.

The emphasis of this JV is to develop an affordable mixed signal chipset that can be used at server/router level and also in mobile PDA applications to provide secure and encrypted communication with the goal of preventing hacking and cyber-attacks.

This JV will take advantage of AmpliTech's industry leadership and experience in RF/Microwave LNA technology and TN's Cyber-security Protocol technology to eliminate the widespread occurrence of corporate and individual cyber-attacks.

In November, Amplitech Group announced the filing of its 10-Q for Q3 2017. AmpliTech reported a decline in gross revenues of 24 percent versus the same period the year prior. The Company experienced its second consecutive quarter with reduced revenue.

However, AmpliTech continued its path towards enhancing and expanding its niche product line and technology through investing in research and development (R&D) in higher margin products for commercial applications. In addition, AmpliTech has invested substantially more into advertising and marketing than any other year in its history.

AmpliTech Group, Inc. (AMPG), closed Friday's trading session at $0.0486, up 4.07%, on 37,396 volume with 13 trades. The average volume for the last 60 days is 70,297 and the stock's 52-week low/high is $0.0296/$0.396.

chart

Patriot Gold Corp. (PGOL)

Real Pennies, OtcWizard, Gold Investment Letter, and Standout Stocks reported earlier on Patriot Gold Corp. (PGOL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Patriot Gold Corp. is a precious metals exploration and production company. Its mission is to discover and develop significant gold and silver assets in Arizona and Nevada. The Company currently holds a portfolio of four projects. These are the Moss project in Arizona and three in Nevada (Bruner, Vernal, and Windy Peak). Patriot Gold is headquartered in Las Vegas, Nevada.

Patriot holds a 3 percent royalty in the Moss Mine in Arizona, an interest in the Bruner gold project in Nevada, and a 100 percent interest in the Vernal and Windy Peak projects in Nevada.

The Moss Mine Project is within the historic Oatman District, 10 miles east of Bullhead City, Arizona and roughly 70 miles southeast of Las Vegas. Northern Vertex Mining Corp. owns the Moss Mine.

The Vernal gold project is in its early stage. This property is roughly 140 miles east-southeast of Reno, Nevada, on the west side of the Shoshone Mountains. The property consists of 12 unpatented mining claims (240 acres).

Patriot Gold owns a 2 percent royalty in the Bruner gold project. The Bruner gold project property is about 130 miles east-southeast of Reno, Nevada. It is at the northern end of the Paradise Range and 45 miles northwest of the Round Mountain Mine. Canamex Resources Corp. owns the Bruner gold project.

The Windy Peak Gold Project comprises 79 unpatented mineral claims in the Fairview mining district in southwest Nevada. Windy Peak is easily accessed. It is around 45 miles southeast of Fallon and 6 miles from Middlegate. The Bruner and Vernal gold projects are in Nevada's Walker Lane, which hosts many major deposits. These include the Goldfield (more than 5 million ounces of post production and present reserves) and the Comstock (more than 8 million ounces).

This past March, Patriot Gold reported that the Moss Mine, owned by Northern Vertex Mining, entered production with the announcement of its first gold pour. In addition, Vertex Mining announced funding of $2,000,000 CDN for continued exploration and a commitment of up to $100 million USD for continued acquisition and development.

Furthermore, in March, Patriot Gold reported that it is exploring its 100 percent-owned Windy Peak gold project in Nevada, and announced permitting is in place for a drilling program. The Company identified a number of drilling targets.

Patriot Gold Corp. (PGOL), closed Friday's trading session at $0.06315, up 0.08%, on 600 volume with 1 trade. The average volume for the last 60 days is 17,761 and the stock's 52-week low/high is $0.0438/$0.11.

chart

Timberline Resources Corp. (TLRS)

InvestorsHub, MarketWatch, and Gold Investment Letter reported on Timberline Resources Corp. (TLRS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Timberline Resources Corp. is a gold exploration and development company. Its operational focus is the State of Nevada. The Company’s flagship Talapoosa Project is a partially permitted, open-pit, heap leach gold project with low capital and operating costs and strong economics. Additionally, its exploration efforts have been centered on its 23 square-mile Eureka land package. This is one of the largest remaining undeveloped gold properties in Nevada. Timberline Resources is headquartered in Coeur d’Alene, Idaho.

The Company entered into a transaction with Gunpoint Exploration Ltd. on March 17, 2015. Timberline Resources acquired the option to purchase 100 percent of the Talapoosa project, positioned in Lyon County, Nevada. The Talapoosa property is a low-sulphidation gold/silver property in the Walker Lane gold trend of western Nevada, roughly 45 kilometers east of Reno.

Talapoosa highlights include an NI 43-101 resource consisting 1,012,802 oz gold (M&I); 233,532 oz gold (Inferred). Furthermore, highlights include near-surface oxide gold ounces totaling 162,581 oz (M&I); 47,745 oz (Inferred).

Talapoosa has well-established infrastructure. The Talapoosa project in Lyon County is where the Company has completed and disclosed a positive Preliminary Economic Assessment (PEA).

Concerning the Eureka land package, it includes Timberline’s Lookout Mountain project and a pipeline of earlier-stage projects, which feature past gold production, historic gold estimates, and/or drill-indicated gold mineralization. Eureka is on the south end of Nevada’s Battle Mountain/Eureka Trend.

At Eureka, Timberline Resources continues to advance its Lookout Mountain and Windfall project areas. In 2012, the Company purchased a large block of patented and unpatented mining claims. These comprise chiefly the entire Seven Troughs gold mining district near Lovelock in Pershing County, Nevada.

The purchased property package encompasses 4,100 acres. It consists of 64 patented and 238 unpatented lode mining claims, all which are under a long-term lease agreement, along with 162 additional unpatented lode mining claims.

Recently, Timberline Resources announced consolidated financial results for its first Fiscal Year (FY) 2018 quarter ended December 31, 2017. The Company reported a consolidated Net Loss of $0.3 million for the quarter ended December 31, 2017. This includes exploration expenditures of $26,000.

Timberline Resources completed a private placement during the quarter. The Company continues to seek capital for the advancement of the Talapoosa gold and silver project. It expects, subject to having sufficient capital, to continue to advance the Talapoosa project toward a pre-feasibility study and further development.

Timberline Resources Corp. (TLRS), closed Friday's trading session at $0.10645, up 12.05%, on 45,842 volume with 15 trades. The average volume for the last 60 days is 96,558 and the stock's 52-week low/high is $0.056/$0.425.

chart

Gopher Protocol, Inc. (GOPH)

Profitable Trader Authority, PennyTrader, OTCtipReporter, Wall Street Mover, PennyStockScholar, and Integrity Solution IR reported on Gopher Protocol, Inc. (GOPH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Gopher Protocol, Inc. is developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology. The Company provides a mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional features.

Gopher Protocol’s Integrated Circuit (IC), called GopherInsight™, and accompanied software, creates a private and secured network for sharing information and adapting to user preferences. The system is self-learning and constantly developing. A development stage company, Gopher Protocol is headquartered in Santa Monica, California.

The Company is developing a real-time, heuristic based, mobile technology. When developed, the mobile technology will consist of a smart microchip, mobile application software and supporting software that run on a server. The system envisions the creation of an international network.

The heart of this system will be its advanced microchip, which will be able to undergo installation in any mobile device worldwide. Gopher Protocol expects that this will result in an internal, private network between all mobile devices using the device through providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and more mobile features.

Gopher Protocol has its licensed technology, the Guardian Patch. The mobile tracking technology will track and protect anything one cares about, with or without GPS (Global Positioning System).

The Guardian Patch is a stick-on tracking device. It protects and tracks everything from a phone to a loved-one or a pet. The Guardian Patch device was conceived as an offshoot of Gopher Protocol’s microchip technology named GopherInsight™.

Gopher Protocol introduced its "dDrone" technology in November 2017. This technology uses Artificial Intelligence (AI) to create what is believed to be the world's first" Smart Drone." Gopher AI drone technology uses machine learning to give drones advanced flight capabilities.

Gopher's AI drone technology can solve complex problems related to geo-locations, weather conditions, and obstacle avoidance. The dDrone AI system is equipped with deep learning, resembling IBM's Watson.

Last month, Gopher Protocol announced that it incorporated UGopherServices Limited in England and Wales. With this incorporation of UGopherServices Limited, Gopher Protocol is looking to expand its platform worldwide. The Company formed UGopherServices Limited, which will operate as a wholly-owned subsidiary.

In addition, in February, Gopher Protocol reported new research and development (R&D) efforts for its MESH Technology. New research includes testing of the Company’s MESH network technology for use in autonomous driving tracking and safety applications. Gopher Protocol’s core tracking technology is founded on AI data in real-time and is presently implemented in the Company’s pet tracking device.

The MESH network is a communications network. It is intended to be made up of radio nodes organized in a mesh topology. A mesh refers to rich interconnection among devices or nodes. Wireless mesh networks frequently consist of mesh clients, mesh routers, as well as gateways.

Gopher Protocol, Inc. (GOPH), closed Friday's trading session at $1.41, up 20.51%, on 470,635 volume with 547 trades. The average volume for the last 60 days is 389,287 and the stock's 52-week low/high is $0.16/$4.85.

chart

ProtoKinetix, Inc. (PKTX)

Willy Wizard, Pick Alerts, Penny stock Profitz, AllPennyStocks, Penny Invest, CoolPennyStocks, TopPennyStockMovers, 777 Stocks, Breaking Bulls, InsideBulls, SmallCapVoice, OTCReporter, Stock Rich, PennyStockAce, Stockpalooza, SuperBirdStocks, WallStAlerts, Stock Market News Alert, HotOTC, StockEgg, and Round Up the Bulls reported earlier on ProtoKinetix, Inc. (PKTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ProtoKinetix, Inc. is a molecular biotechnology company listed on the OTC Markets’ OTCQB. The Company has developed and patented a family of hyper stable, potent glycopeptides (Anti-Aging GlycoPeptide - AAGP™), which enhance engraftment and protection of transplanted cells utilized in regenerative medicine. ProtoKinetix has its corporate headquarters in Marietta, Ohio.

Because of the anti-inflammatory effect of AAGP™ molecules, the Company is presently targeting the direct treatment of diseases that have a significant inflammatory component. ProtoKinetix’s, AAGP™, is an antifreeze glycopeptide. It imitates a naturally occurring glycoprotein found in Arctic fish.

The Company’s AAGP™ molecule is helping to considerably improve the efficacy of Cell Transplant Treatments for diabetes. ProtoKinetix has broad patent protection for its portfolio of anti-aging glycopeptides.

Its anti-aging glycopeptide is trademarked AAGP™. This is a small (580.96 Daltons), stable, synthetic replica of the larger (>2,600 Daltons), less stable AFGP that has been found to have protective properties in nature.

The small size of AAGP™ enables it to penetrate cells. It allows it to pass through cell and capillary junctions in vivo. Also, its bioactivity at a range of pHs (5.3-10.3) and temperatures (-196°C to 22°C) and efficiency at concentrations (1mg/ml) is well under its toxic dose (50mg/ml). This makes it a candidate to enter the next stages of translational research.

ProtoKinetix and Proactive Immune Sciences entered into a joint research collaboration. The objective of the research is to test the effect of the patented anti-aging glycopeptide AAGP™ on the immune cell cryopreservation protocols used by Proactive Immune Sciences.

ProtoKinetix announced this past January that it entered into a research agreement with The University of British Columbia (UBC), under the direction of principal investigator Dr. Kelly McNagny, Professor, Faculty of Medicine, Department of Medical Genetics. The research agreement is to test and establish the effect of AAGP™ on monoclonal antibody production and bone marrow recovery.

Recently, ProtoKinetix announced that it executed a Material Transfer Agreement (MTA) with a reputed biotechnology company having several international offices on four continents. Under the MTA, ProtoKinetix and this company are working together to test the effects AAGP® have on three projects.

One project is Cryopreservation of Primary Mammalian Tissue Cells. A second project is Enhancing the Viability of Primary Mammalian Cells. The third project is Cell Lines Under Stressed Culture Conditions.

ProtoKinetix President and Chief Executive Officer, Mr. Clarence E. Smith said, “We are delighted to be collaborating with this reputed, international biotechnology company with facilities worldwide. If testing proves to be successful, this may give ProtoKinetix the first opportunity to license out AAGP®.”

ProtoKinetix, Inc. (PKTX), closed Friday's trading session at $0.0691, down 7.87%, on 128,008 volume with 14 trades. The average volume for the last 60 days is 103,622 and the stock's 52-week low/high is $0.03/$0.12.

chart

The QualityStocks Company Corner

Zenosense, Inc. (OTCQB: ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO).

Zenosense (OTC: ZENO), through the development of MIDS Cardiac™, seeks to provide a technology that delivers laboratory-level accuracy at the point of care. To view the full article, visit: http://nnw.fm/n7wGV.

Zenosense, Inc. (OTCQB: ZENO) (the “Company”) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense is primarily focused on the development and commercialization of MIDS Cardiac™ through the Company’s joint venture ownership in MIDS Medical Limited (“MML”). MIDS Cardiac is in development as a cost-effective, handheld Point of Care (“POC”) diagnostic device and disposable test strip for the early, rapid detection of suspected acute myocardial infarction (“AMI”, or “heart attack”).

Identification of very low levels of cardiac markers can significantly accelerate critical triage, diagnosis, treatment and disposition of patients reporting chest pain. Cardiac troponin is well documented as the preferred biomarker for diagnosis of AMI, with evidence continuing to demonstrate that high sensitivity troponin is the most powerful prognostic biomarker for the assessment of cardiovascular risk in the general population. However, highly sensitive troponin assays are currently available only on state of the art, central laboratory analyzers. These analyzers are extremely expensive, not generally available at the POC and slow to turnaround results (typically 60 minutes) when time is critical.

True, high-sensitivity devices are not available in smaller handheld devices at the POC, where they are most needed. This is because the optical detection systems generally used in central laboratory analyzers cannot be effectively miniaturized.

MIDS Cardiac uses the patented MIDS technology platform, exclusively available to MML. Instead of using conventional optical detection, MIDS can detect and quantify assay beads nano-magnetically. This means it can be incorporated in a small device expected to achieve highly sensitive detection levels, which can support true high sensitivity cardiac biomarker tests in emergency settings, at the POC.

Harnessing world-class expertise, the MML laboratory is located at the prestigious Sci-Tech Daresbury campus in the U.K., internationally recognized for leading-edge, scientific research and commercial development. MML has the sole rights to the MIDS technology platform, which is protected by patent applications already granted in China and the USA, and applications now in the national phase in all other key geographic areas.

MIDS Cardiac aims to provide a single troponin I or T test within 3 minutes and three panel assay (additional cardiac biomarkers) on a disposable test strip within 8 minutes, using a hand-held device costing a fraction of the price of laboratory analyzers.

MIDS Cardiac should only require a pin prick of blood for a single assay test carried out on an easy-to-use, disposable microfluidic test strip. MIDS Cardiac is being designed to be operated quickly by minimally trained personnel, producing a simple to interpret result in emergency settings, even in the back of an ambulance.

Initial testing of the electronic and microfluidic components of the MIDS Cardiac “Hybrid Strip” system was completed in November 2017. The Hybrid Strip system used for development testing aims to replicate as closely as possible a fully integrated Lab on Chip MIDS test strip set-up. Development testing was conducted on both the assembled hybrid unit and its electronic and microfluidic components separately, focusing mainly on the electronics of the magnetic sensing system.

Testing revealed that a variety of brands and sizes of commercially available assay beads could be magnetically detected in very low quantities, including samples of beads that were previously undetectable. In several instances, the current “limit of detection” appeared to already be at or near to the range advised by MML’s assay consultants as suitable for a high sensitivity troponin assay.

Dr. Nasser Djennati, MML’s Managing Director and Chief Scientific Officer, said; “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Cardiovascular disease is the leading cause of death in the western world, accounting for more than 17 million deaths in Europe and the United States alone. Nearly 20 million patients each year visit an emergency room with reports of chest pain, with hundreds of millions spent on unnecessary admissions to the hospital. Zenosense Inc. is confident MIDS Cardiac will deliver unparalleled levels of accuracy, speed, reliability, ease of use and cost savings, making it the future device of choice for hospitals, emergency rooms, medical practitioners, paramedics and in low-resource settings.

The MIDS technology is also seen as having a far wider application, with the platform being capable of performing Point of Care immunoassay tests for a vast array of common healthcare concerns, a market projected to be worth $23.7 billion per year worldwide by 2019. The medical testing market as a whole is projected to be worth $53.34 billion by 2021. Zenosense believes the MIDS technology could be the most significant advance in diagnostic testing services in decades.

Zenosense, Inc. (ZENO), closed the day's trading session at $0.385, up 4.05%, on 109,680 volume with 36 trades. The average volume for the last 60 days is 267,737 and the stock's 52-week low/high is $0.15/$0.895.

Recent News

chart

SinglePoint, Inc. (OTCQB: SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program discussing “money and what makes it happen.” To view the full interview, visit: http://nnw.fm/Afb8c. To view the full press release, visit: http://nnw.fm/Ks0Ig.

SinglePoint, Inc. (OTCQB: SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.03449, up 7.78%, on 2,059,079 volume with 128 trades. The average volume for the last 60 days is 6,678,098 and the stock's 52-week low/high is $0.0235/$0.415.

Recent News

chart

Pacific Software, Inc. (OTC: PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software, Inc. (OTC: PFSF) announces today it has signed a definitive agreement to begin construction of its proprietary e-commerce trade platform. Pacific Software, Inc. executed a definitive agreement with Cobalt 47 Technologies LTD, a spin-off of KBQuest Group, to begin construction of its multi-lingual e-commerce B2B and B2C trade platform.  The platform is expected to be in production by November 2018 and will integrate blockchain technology solutions including the Company’s Agri-Blockchain. 

Pacific Software, Inc. (OTC: PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture, cannabis, and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

Agriculture
For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Cannabis
Perceiving blockchain as an ideal mechanism for the complexities of the cannabis industry, Pacific Software will strive to improve the transparency, compliance, and efficiency of the “seed-to-sale” supply chain in states where the plant is legal.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.25, even for the day. The average volume for the last 60 days is 55 and the stock's 52-week low/high is $4.00/$5.25.

Recent News

chart

Pressure BioSciences Inc. (OTCQB: PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences, Inc. (OTCQB: PBIO) (''PBI'' and the ''Company'') today announced that the Company will host a teleconference to discuss its Second Quarter 2018 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by telephone or via a link on the Company's website approximately one day after the teleconference). Also today, NetworkNewsWire released a report on the company detailing how PBIO is forecast to grow at a compound annual growth rate (CAGR) of 76 percent in the next five fiscal years from 2018 to 2022, according to a Zacks Research Report issued on July 26, 2018 (http://nnw.fm/F3GhM).

Pressure BioSciences Inc. (OTCQB: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.60, even for the day, on 500 volume with 2 trades. The average volume for the last 60 days is 1,107 and the stock's 52-week low/high is $0.70/$5.00.

Recent News

chart

Consorteum Holdings, Inc. (OTC: CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH).

Software development and mobile publishing company Consorteum Holdings (OTC: CSRH) is taking aim at the online gambling market with its Universal Mobile Interface™ (“UMI”) platform. To view the full article, visit: http://nnw.fm/5DNBa.

Consorteum Holdings, Inc. (OTC: CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company’s commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ (“UMI”) solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company’s UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum’s wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company’s UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI’s technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum’s primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum’s management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum’s management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.

Consorteum Holdings, Inc. (CSRH), closed the day's trading session at $0.0016, even for the day. The average volume for the last 60 days is 4,512,172 and the stock's 52-week low/high is $0.0006/$0.0085.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

NetworkNewsAudio announces the Audio Press Release (APR) featuring Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX) titled "From Sunshine to Snow: Self-Driving Car Manufacturers Face the Tough Weather Challenge." To hear the NetworkNewsAudio version, visit http://nnw.fm/K24qS. To read the original editorial, visit http://nnw.fm/J0Wx3. Also today, NetworkNewsWire released a report on the company detailing how FRSX is committed to leading the way in providing inimitable automotive vision systems solutions and growing its foothold in the industry while addressing customers’ needs. To view the full article, visit: http://nnw.fm/6aPaM.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $2.83, off by 1.05%, on 5,791 volume with 18 trades. The average volume for the last 60 days is 56,278 and the stock's 52-week low/high is $2.44/$8.20.

Recent News

chart

Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

CannabisNewsAudio announces the Audio Press Release (APR) titled "Specific Therapeutic Benefits of Cannabidiol (CBD) Validated by FDA," featuring Marijuana Company of America Inc. (OTC: MCOA). To hear the CannabisNewsAudio version, visit: http://cnw.fm/MrSC7. To read the original editorial, visit: http://cnw.fm/T0atR.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0297, up 1.64%, on 3,055,101 volume with 169 trades. The average volume for the last 60 days is 7,874,101 and the stock's 52-week low/high is $0.022/$0.0728.

Recent News

chart

ChineseInvestors.com (OTCQB: CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com, Inc. (OTCQB: CIIX), a company focused on providing financial information and services to the Chinese-speaking community worldwide, will soon spin off its cannabis-related products into the wholly owned subsidiary ChineseHempOil.com, Inc. The spinoff was originally scheduled for May 31, 2018, but was temporarily postponed as CIIX continues to develop domestic sales channels. Also today, NetworkNewsWire released a report on the company detailing how CIIX is taking a lead role in educating investors in the 101s and advanced topics in cryptocurrencies. To view the full article, visit: http://nnw.fm/sG1Bc.

Founded in 1999, ChineseInvestors.com (OTCQB: CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.47, off by 8.74%, on 238,914 volume with 97 trades. The average volume for the last 60 days is 93,707 and the stock's 52-week low/high is $0.365/$1.58.

Recent News

chart

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile (TSX.V: LITH) (OTCQB: LTMCF) recently reported early results from its exploratory drilling program at its Ollague property. To view the full article, visit: http://nnw.fm/zCkz9.

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.5854, off by 4.19&, on 6,695 volume with 8 trades. The average volume for the last 60 days is 48,358 and the stock's 52-week low/high is $0.535/$0.97.

Recent News

chart

Virtual Crypto Technologies Inc. (OTCQB: VRCP)

The QualityStocks Daily Newsletter would like to spotlight Virtual Crypto Technologies Inc. (VRCP).

NetworkNewsAudio announces the Audio Press Release (APR) titled "ATMs Provide Potential Route for Cryptocurrency into the Mainstream," featuring Virtual Crypto Technologies Inc. (OTCQB: VRCP). To hear the NetworkNewsAudio version, visit: http://nnw.fm/Vw3Yw. To read the original editorial, visit: http://nnw.fm/puY7b.

Virtual Crypto Technologies Inc. (OTCQB: VRCP) is a developer of software and hardware for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. The company’s proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

With NetoBit Trader, cryptocurrency holders enjoy immediate confirmation of Bitcoin and its crypto equivalents at the best crypto exchange rate at the point of transaction – providing a major breakthrough in the quest to bring cryptocurrencies to the mass market. Virtual Crypto’s cryptocurrency ATM, embedded with currency exchange transaction validation (CETV) in its hardware and software, accepts and dispenses cash and cryptocurrency in seconds.

Virtual Crypto’s NetoBit Trader and mobile retail point-of-sale platform incorporates advanced technologies tailored to the needs of primary market players, users, investors, and business owners. Virtual Crypto’s platform bridges the three main functions of the cryptocurrency sector – exchanges, wallets and payments – to the world of fiat exchanges, granting access to immediate cash exchanges between consumers and businesses worldwide.

NetoBit Trader’s over-the-counter, two-way transaction solution is available through one app, providing online cryptocurrency transactions at ecommerce and gaming portals. The app provides real-time cryptocurrency validation and exchange, easy buying and selling of Bitcoin with cash, enables traders to buy and trade crypto, and gamers to transfer cryptocurrency into cash after play. Crypto users can withdraw funds from their crypto accounts through a NetoBit cryptocurrency ATM or software-enabled tablet, and consumers can purchase retail with crypto from businesses that offer and use the NetoBit software.

The company’s newly redesigned corporate website, www.virtual-crypto.com, delivers a simple, clean design with enhanced functionality, features and navigation. Virtual Crypto’s new corporate website includes:

  • Downloadable NetoBit Trader app link and contact forms for more information
  • MarketWatch provides real-time tracking of the Bitcoin market, with other currencies to follow
  • Improved security utilizing https certificates to protect personal information and site integrity
  • Media room with downloadable product brochures, corporate presentations and other relevant content
  • Investor’s page provides transparency to investors with direct access to Virtual Crypto’s progress through press releases, SEC filings, senior management team bios, and stock performance charts
  • Social Media integration with buttons for LinkedIn, Twitter and Facebook jump to Virtual Crypto’s social media profiles, providing real-time updates from the online community

“Our primary objective is to make cryptocurrencies accessible to everyone, and that was the motivation for our redesign,” said Alon Dayan, Chief Executive Officer of Virtual Crypto. “The updated content provides real value for our customers, shareholders and employees, showcasing our products and services, in an intuitive, easy to navigate way.”

Virtual Crypto’s strategic vision of “Cryptocurrency Made Easy” allows crypto traders and users to overcome the complex hurdles currently hampering the cryptocurrency sphere.

Virtual Crypto Technologies Inc. (VRCP), closed the day's trading session at $0.1235, off by 4.26%, on 5,470 volume with 7 trades. The average volume for the last 60 days is 31,301 and the stock's 52-week low/high is $0.0125/$0.38.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV: PQE; OTC: PQEFF; FSE: PQCF) has finalized continuity testing at its Asphalt Ridge facility and is making final arrangements for continuous operations and marketing activities. Also today, NetworkNewsWire released a report on the company detailing how PQEFF is a corporation focused more on the high-margin commercialization of its licensing technology than its oil commodities business.

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $1.3799, up 2.21%. on 867,744 volume with 847 trades. The average volume for the last 60 days is 314,056 and the stock's 52-week low/high is $0.28/$1.8892.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) is a premium food and beverage company that develops foods, beverages and supplements infused with cannabidiol (“CBD”) for global distribution. To view the full article, visit: http://nnw.fm/6wOw2.

Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTCQX: OTCQX) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.

Regulations

Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.

The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

3 Wholly Owned Subsidiaries

  • Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at www.Phivida.com.
  • Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
  • Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.

WeedMD-Phivida

Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.

Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.

Strategic Agreements

Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.

Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.53, off by 9.40%, on 51,421 volume with 33 trades. The average volume for the last 60 days is 25,551 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.